Yamada Y, Takashi M, Sakata T, Nakano Y, Takagi Y, Hibi H, Miyake K
Department of Urology, Nagoya University School of Medicine.
Hinyokika Kiyo. 1995 Oct;41(10):781-7.
We earlier demonstrated that simultaneous administration of EHEN and uracil for 3 weeks resulted in enhancement of renal carcinogenesis in F344 female rats. Therefore, to establish a model of renal carcinogenesis in rats that can induce advanced renal carcinoma at a high incidence, differences in the susceptibility to N-ethyl-N-hydroxyethylnitrosamine (EHEN) and uracil of the kidneys in male and female rats of two strains were examined. Group 1 (male Wistar rats), group 2 (female Wistar rats), group 3 (male F344 rats), and group 4 (female F344 rats) received a 3-week simultaneous administration of 0.05% EHEN in the drinking water and 3% uracil in the diet after one week's acclimation. In all the above four groups, the rats were thereafter given a basal diet and water without chemical addition for a 29-week period. Group 5 (male Wistar rats), group 6 (female Wistar rats), group 7 (male F344 rats) and group 8 (female F344 rats) received no chemicals for the entire 33 weeks. At the end of the experiment, renal adenocarcinomas were found in 85, 68, 14 and 0% of the rats in groups 1, 2, 3 and 4, respectively. The incidence of adenomas and adenocarcinomas in Wistar rats were significantly greater than in F344 rats (p < 0.0001). These findings indicate strain and possibly sex differences in kidney carcinogenesis in rats treated with EHEN and uracil, and simultaneous administration of the two agents to male Wistar rats might have an advantage for models to induce advanced renal carcinoma at a high incidence.
我们之前证明,在F344雌性大鼠中同时给予N-乙基-N-羟乙基亚硝胺(EHEN)和尿嘧啶3周会导致肾癌发生增强。因此,为了建立一种能高发病率诱导晚期肾癌的大鼠肾癌发生模型,研究了两种品系雄性和雌性大鼠肾脏对EHEN和尿嘧啶敏感性的差异。第1组(雄性Wistar大鼠)、第2组(雌性Wistar大鼠)、第3组(雄性F344大鼠)和第4组(雌性F344大鼠)在适应1周后,接受为期3周的同时给予饮用水中0.05%的EHEN和饮食中3%的尿嘧啶。在上述所有四组中,此后大鼠给予无化学添加的基础饮食和水,持续29周。第5组(雄性Wistar大鼠)、第6组(雌性Wistar大鼠)、第7组(雄性F344大鼠)和第8组(雌性F344大鼠)在整个33周内未接受化学物质。实验结束时,第1、2、3和4组大鼠中肾腺癌的发生率分别为85%、68%、14%和0%。Wistar大鼠腺瘤和腺癌的发生率显著高于F344大鼠(p < 0.0001)。这些发现表明在用EHEN和尿嘧啶处理的大鼠肾脏致癌过程中存在品系差异,可能还有性别差异,并且同时向雄性Wistar大鼠给予这两种药物可能对高发病率诱导晚期肾癌的模型具有优势。